Natalie J. Shiff

1.7k citations

57 papers · 579 indexed · h-index 16

Speech and Hearing top 2%
- Adolescent and Pediatric Healthcare 21
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 42
Rheumatology top 5%
- Spondyloarthritis Studies and Treatments 18
- Rheumatoid Arthritis Research and Therapies 17
- Systemic Lupus Erythematosus Research 7
Pediatrics, Perinatology and Child Health
Immunology
- Psoriasis: Treatment and Pathogenesis 13
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 7
Clinical Psychology
- Family and Disability Support Research 7

Co-authors: Lori B. Tucker Jaime Guzmán Kiem Oen Lisa M. Lix Roberta Berard Susanne M. Benseler Roman Juřenčák Ciarán M. Duffy
Cited by: Speech and Hearing Hematology Rheumatology
Journals: Annals of the Rheumatic Diseases (3 papers)Journal of Medical Internet Research (1 paper)Lara D. Veeken (2 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Natalie J. Shiff

56 papers receiving 573 citations

Peers

Countries citing papers authored by Natalie J. Shiff

Since Specialization

Citations

This map shows the geographic impact of Natalie J. Shiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie J. Shiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie J. Shiff more than expected).

Fields of papers citing papers by Natalie J. Shiff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie J. Shiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie J. Shiff. The network helps show where Natalie J. Shiff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Natalie J. Shiff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Natalie J. Shiff Line = papers co-authored together Natalie J. Shiff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials Rheumatology and Therapy ·Jeffrey R. Curtis,Atul Deodhar,Enrique R. Soriano,Emmanouil Rampakakis,M. Shawi,Natalie J. Shiff,Cheng‐Long Han,William Tillett,Dafna D Gladman	2024	2
2	Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors Advances in Therapy ·Philip J. Mease,Shannon Ferrante,Natalie J. Shiff,Timothy Fitzgerald,Soumya D. Chakravarty,Jessica A. Walsh	2024	1
3	Persistent Patient‐Level Effect of Guselkumab at Consecutive 8‐Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2‐Year, Phase 3, Randomized, Controlled Study ACR Open Rheumatology ·Philip J. Mease,Xenofon Baraliakos,Vinod Chandran,Enrique R. Soriano,Peter Nash,Atul Deodhar,Emmanouil Rampakakis,Natalie J. Shiff,Soumya D. Chakravarty,M. Shawi,Joseph F. Merola,Iain B. McInnes	2024	2
4	Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry ACR Open Rheumatology ·Philip J. Mease,Alexis Ogdie,John Tesser,Natalie J. Shiff,Ruizhi Zhao,Soumya D. Chakravarty,Michael Kelleman,Rhiannon Dodge,Robert R. McLean,Aaron Broadwell,Arthur Kavanaugh,Joseph F. Merola	2024	1
5	Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study RMD Open ·Laura C. Coates,Laure Gossec,Miriam Zimmermann,M. Shawi,Emmanouil Rampakakis,Natalie J. Shiff,Alexa P. Kollmeier,Xie L. Xu,Peter Nash,Philip J. Mease,Philip Helliwell	2024	5
6	Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors Drugs - Real World Outcomes ·Jessica A. Walsh,Iris Lin,Ruizhi Zhao,Natalie J. Shiff,Laura Morrison,Bruno Émond,Louise Yu,Samuel Schwartzbein,Patrick Lefèbvre,Dominic Pilon,Soumya D. Chakravarty,Philip J. Mease	2024	3
7	Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis Rheumatology and Therapy ·Jeffrey R. Curtis,Iain B. McInnes,Proton Rahman,Dafna D. Gladman,Steven L. Peterson,Feifei Yang,Oluwakayode Adejoro,Alexa P. Kollmeier,Natalie J. Shiff,Chenglong Han,M. Shawi,William Tillett,Philip J. Mease	2024	0
8	AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY Annals of the Rheumatic Diseases ·I. Mcinnes,Enrique R. Soriano,Lai‐Shan Tam,Natalie J. Shiff,M. Shawi,E. Rampakakis,John J. Curtis	2023	1
9	Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry Rheumatology and Therapy ·Philip J. Mease,Alexis Ogdie,John Tesser,Natalie J. Shiff,Iris Lin,Soumya D. Chakravarty,Michael Kelleman,Rhiannon Dodge,Robert R. McLean,Aaron Broadwell,Arthur Kavanaugh,Joseph F. Merola	2023	9
10	Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study BMC Rheumatology ·Aaron Broadwell,Joy Schechtman,Douglas Conaway,Alan Kivitz,Natalie J. Shiff,Shawn C. Black,Stephen Xu,Wayne Langholff,Sergio Schwartzman,Jeffrey R. Curtis	2023	1
11	Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry Clinical Rheumatology ·John Tesser,Iris Lin,Natalie J. Shiff,Soumya D. Chakravarty,Gabriela Schmajuk,Nevin Hammam,Sheetal Desai	2022	2
12	Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis JCR Journal of Clinical Rheumatology ·Atul Deodhar,Soumya D. Chakravarty,Natalie J. Shiff,Kim Hung Lo,Stephen Xu,Elizabeth C. Hsia,Abhijeet Danve,John D. Reveille	2022	1
13	A Population‐Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care Arthritis Care & Research ·Claire Barber,Deborah A. Marshall,Elena Szefer,Cheryl Barnabé,Natalie J. Shiff,Vivian P. Bykerk,Joanne Homik,Carter Thorne,Vandana Ahluwalia,Susanne M. Benseler,Dianne Mosher,Marinka Twilt,Diane Lacaille	2020	15
14	Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis Journal of Medical Internet Research ·Jennifer Stinson,Chitra Lalloo,Amos Hundert,Sarah Campillo,Tania Cellucci,Paul Dancey,Ciarán M. Duffy,Janet Ellsworth,Brian M. Feldman,Adam M. Huber,Nicole Johnson,G. Majella de Jong,Kiem Oen,Alan Rosenberg,Natalie J. Shiff,Lynn Spiegel,Shirley M. L. Tse,Lori B. Tucker,J. Charles Victor	2020	19
15	Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis Pediatric Rheumatology ·Claire Barber,Cheryl Barnabé,Susanne M. Benseler,Ricky Chin,Nicole Johnson,Nadia Luca,Päivi Miettunen,Marinka Twilt,Dwaraka Veeramreddy,Natalie J. Shiff,Heinrike Schmeling	2020	11
16	Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures The Journal of Rheumatology ·Claire Barber,Diane Lacaille,Peter Faris,Dianne Mosher,Steven J. Katz,Jatin N. Patel,Sharon Zhang,Karen Yee,Cheryl Barnabé,Glen Hazlewood,Vivian P. Bykerk,Natalie J. Shiff,Marinka Twilt,Jennifer Burt,Susanne M. Benseler,Joanne Homik,Deborah A. Marshall	2020	9
17	Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care The Journal of Rheumatology ·Claire Barber,Carter Thorne,Vandana Ahluwalia,Jennifer Burt,Diane Lacaille,Deborah A. Marshall,Glen Hazlewood,Dianne Mosher,Lisa Denning,Ildiko Szamko,Ricky Chin,Sean Hamilton,Susanne M. Benseler,Marinka Twilt,Natalie J. Shiff,Vivian P. Bykerk,Joanne Homik,Cheryl Barnabé	2018	13
18	What Matters Most for Patients, Parents, and Clinicians in the Course of Juvenile Idiopathic Arthritis? A Qualitative Study The Journal of Rheumatology ·Jaime Guzmán,Oralia Gómez-Ramírez,Roman Juřenčák,Natalie J. Shiff,Roberta Berard,Ciarán M. Duffy,Kiem Oen,Ross E. Petty,Susanne M. Benseler,Rollin Brant,Lori B. Tucker	2014	30
19	The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates Rheumatology International ·Natalie J. Shiff,Lisa M. Lix,Lawrence Joseph,Ciarán M. Duffy,Lori B. Tucker,Lawrence W. Svenson,Patrick Bélisle,Sasha Bernatsky	2014	11
20	Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model Photodermatology Photoimmunology & Photomedicine ·Iltefat Hamzavi,Natalie J. Shiff,Magda Martinka,Zhiwei Huang,David I. McLean,Haishan Zeng,Harvey Lui	2006	9

About Natalie J. Shiff

Natalie J. Shiff is a scholar working on Hematology, Speech and Hearing and Rheumatology, having authored 57 papers that have together received 579 indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (42 papers), Adolescent and Pediatric Healthcare (21 papers), Spondyloarthritis Studies and Treatments (18 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Psoriasis: Treatment and Pathogenesis (13 papers), Acute Lymphoblastic Leukemia research (7 papers), Systemic Lupus Erythematosus Research (7 papers) and Family and Disability Support Research (7 papers). The work is most often cited by research in Speech and Hearing (219 citations), Hematology (338 citations) and Rheumatology (179 citations). Natalie J. Shiff has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Lori B. Tucker, Jaime Guzmán, Kiem Oen, Lisa M. Lix, Roberta Berard, Susanne M. Benseler, Roman Juřenčák, Ciarán M. Duffy, Paul R. Fortin and Arif Jetha. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of Medical Internet Research and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact